MESOmesotheliomaccRCCDLBCLClear cell renal cell carcinomaLUSCCOADcolon adenocarcinomadiffuse large B-cell lymphoma
…as 23.3 for ccRCC (kidney), 1.9 for DLBCL (spleen), and 3.6 for MESO (lung). In comparative analyses, CD70 expression in ccRCC was s…
34articles mentioning diseases
35disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: hematologic malignancies ×
hematologic malignancies
This disease is selected. Its supporting articles are shown below.
Articles mentioning hematologic malignancies
34 articles · page 2 of 3solid tumorshematologic malignanciesCAR-TCAR-T therapies
…therapy has been successful against solid tumors. 1 Efficacy in solid tumors is hampered by various factors such as antigen variation, lack …
Solid tumorsovarian cancersbreasthematologic malignanciesimmunotherapies
…Background Solid tumors such as breast, lung, pancreatic, colorectal, and ovarian cance…
solid tumorsDIPGpediatric brain tumorshematologic malignanciespediatric high-grade gliomasdiffuse intrinsic pontine glioma (DIPG)NLVIL13Rα2-targeting 41BB-based CARCAR T cell therapyNLVPMVATV+2 more
… landscape for hematologic malignancies, but its application in solid tumors—especially pediatric brain tumors—remains limited by multiple b…
86.3%
pediatric brain tumorsmedulloblastomahematologic malignanciespediatric gliomaU87GSK3685032ZebularineAZAazacytidineChimeric antigen receptor (CAR) T-cell therapy
… treatment for hematologic malignancies, but its application in pediatric brain tumors remains limited due to poor persistence and T-cell exhaustion. …
metastatic gastric cancersolid tumorshematologic malignanciesChimeric Antigen Receptor T-cell (CAR-T) therapyCanFinis Therapeutics
…These data support the advancement of a novel CAR-T therapy for metastatic gastric cancer and demonstrate the potential of TME relevant validation to acc…
Ewing Sarcomasolid tumorsrhabdomyosarcomaosteosarcomaglioblastomahematologic malignanciesTC71Prostate Canceradult cancersAZD0754
…ng osteosarcoma (143B, SAOS2), rhabdomyosarcoma (RD, Rh30), and Ewing Sarcoma (TC71), were evaluated by ELISA for TGFB cytokine secretion. We…
hepatocellular carcinomasolid tumorsHCChematologic malignanciesNational Natural Science Foundation of China GrantsNanfang HospitalCAR-NK therapyGRGZ2022330CAR-NK cell therapyIL-15-armored CAR+1 more
…lunteers. Animal experiments related to CAR-NK cell therapy for hepatocellular carcinoma were approved by the Institutional Animal Care and Use Committe…
hematologic malignanciesautoimmune diseasesAIDIITAutologous CAR-T cell therapies
…s CAR-T cell therapies have demonstrated remarkable efficacy in hematologic malignancies and are showing promise in treating autoimmune diseases (AID) d…
solid tumorshematologic malignanciesIACUC
…uch transformative efficacy, however, has yet to be realized in solid tumors where CAR-T activity is hindered by poor trafficking and infilt…
systemic lupus erythematosusautoimmune diseasehematologic malignanciesimmune rejectiondaratumumabisatuximabAAALAC-approved facilityMezagitamabanti-CD38 monoclonal antibodies
…):2105–2114. PMID: 29296857McDonnell SRP, et al. Mezagitamab in systemic lupus erythematosus: clinical and mechanistic findings of CD38 inhibition in an aut…
epithelial cancersmelanomametastatic cervical cancerhematologic malignanciesepithelial malignanciescervical cancerscervical cancerepithelial cancerNCT01585428METTL17 E279K
… potential in hematologic malignancies and melanoma, but not in epithelial cancers, the most common malignancy type. Here, we report ongoing compl…